0 Recommendations

Preventing child deaths from DR-TB - MSF and Sentinel Project-hosted workshop at Union KL Conference

By Joanna Keenan | 15 Oct, 2012

43rd World UNION Conference on Lung Health
Kuala Lumpur, Malaysia 2012

Register now for “Preventing child deaths from drug resistant tuberculosis”
- A workshop hosted by Médecins Sans Frontières (MSF) and the Sentinel
Project on Pediatric Drug-Resistant Tuberculosis

Date: Wednesday November 14, 2012
Time: 09.00 – 12.30
Location: Kuala Lumpur Convention Centre, (room to be confirmed).
Workshop registration FREE with Conference registration

Chair: Steve Graham
Presentations, followed by discussion:
1. An introduction to the Sentinel Project on Pediatric DR-TB
Mercedes Becerra (USA)

2. Research meeting the needs of children with DR-TB: an update on progress
Soumya Swaminathan (India)

3. Introducing DR-TB diagnosis and treatment for children into TB
programmes: a case study from Tajikistan
Bern-Thomas Nyang'wa (UK)

4. The use of practical tools and approaches to the diagnosis and treatment
of children with DR-TB
James Seddon (UK)

5. Children in the evolving TB epidemic: future perspectives and priorities
Ben Marais (Australia)

Joanna Keenan
Press Officer
Médecins Sans Frontières - Access Campaign
E: joanna.keenan[at]geneva.msf.org
T: twitter.com/joanna_keenan




Sophie Beauvais Replied at 10:55 AM, 19 Oct 2012

Thanks for sharing Joanna. Also just received announcement for the below peds session at Union fyi:
Making markets work for tuberculosis: fostering a healthy micromarket for paediatric TB medicines through innovative market approaches

UNITAID-Sponsored Satellite Symposium
at the 43rd Union World Conference on Lung Health, Kuala Lumpur, Malaysia
Thursday 15 November 2012
5.00 – 6.30 pm
Kuala Lumpur Convention Centre, Plenary Theatre

Children with TB have consistently poor access to quality medicines tailored for their needs. Despite the urgent need for new child-friendly formulations, market barriers to innovation remain a challenge. Unclear regulatory pathways, product development challenges, and other serious obstacles require targeted intervention. This session will examine potential solutions and define new approaches to fostering a healthy, dynamic market for paediatric TB medicines.

Melvin Spigelman, President and Chief Executive Officer, TB Alliance
Carol Nawina Nyirenda, Community Initiative for TB, HIV/AIDS & Malaria, Zambia

Stephen M. Graham, Chair, Child TB subgroup, WHO Stop TB Partnership, Setting the scene: urgent unmet needs in paediatric TB, and targets for future product development
Lisa Hedman, Technical Officer, Essential Medicines and Pharmaceutical Policies, WHO, Defining the hurdles: challenges in product development and paediatric regulatory pathway
David Ripin, Executive Vice President of Access Programs, Clinton Health Access Initiative, Aggregating demand and other ‘pull’ mechanisms: what has worked and where other tools are needed for paediatric TB
Janet Ginnard, Technical Officer, Market Dynamics, UNITAID, A donor perspective: activities to foster a healthy micromarket for paediatric TB medicines

To register for this side event please contact Fabienne Maertens at

World Health Organization - 20, avenue Appia
CH-1211 Geneva 27 - Switzerland

This Community is Archived.

This community is no longer active as of December 2018. Thanks to those who posted here and made this information available to others visiting the site.